Clariane SECHIX:CLARIP 63 Receivables Turnover is 5.94 as of Dec. 2025. GuruFocus rates CHIX:CLARIP with a GF Score™ of 63/100 and a GF Value™ of €2.47 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 655 Healthcare Providers & Services companies, Clariane SE ranks better than 69.01% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Clariane SE's Revenue for the
six
months ended in Dec. 2025 was €2,655 Mil. Clariane SE's average Accounts Receivable for the
six
months ended in Dec. 2025 was €447 Mil.
Hence, Clariane SE's Receivables Turnover for the
six
months ended in Dec. 2025 was 5.94.
Clariane SE (CHIX:CLARIp) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Clariane SE Receivables Turnover Related Terms
Clariane SE Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Clariane SE's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:CLARIP vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Clariane SE's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Clariane SE's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (CHIX:CLARIP) has a Receivables Turnover of 5.94 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Clariane SE and its competitors. According to the industry distribution chart, Clariane SE ranks #203 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 31%.
Is Clariane SE's Receivables Turnover too high?
Clariane SE's current Receivables Turnover is 5.94. The Healthcare Providers & Services industry median Receivables Turnover is 7.71. Clariane SE's value of 5.94 is 23% below this industry median. Based on the distribution chart, Clariane SE ranks #203 out of 655 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clariane SE has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #203 out of 655 companies for Receivables Turnover. This puts Clariane SE in the upper half of its industry. The industry median Receivables Turnover is 7.71. Clariane SE's value of 5.94 is 23% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.71, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current Receivables Turnover of 5.94 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Receivables Turnover is 5.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.47, compared to a current price of €4.13 — trading 67% above its estimated fair value. The current Receivables Turnover is 5.94 and 23% below the Healthcare Providers & Services industry median of 7.71. Clariane SE's overall GF Score™ is 63/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Receivables Turnover is 5.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.13 is trading 67% above its estimated GF Value™ of €2.47.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for CHIX:CLARIP:
Receivables Turnover: 5.94
GF Value™: €2.47 vs. price of €4.13 (67% above fair value)
Industry Position: 23% below the Healthcare Providers & Services median (#203 of 655)
No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
63GF Score
Get the complete analysis for CHIX:CLARIP
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CLARIP has been successfully added to your 
